Clinical Use of Andante SmartStep System in Gait Rehabilitation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00268658
Recruitment Status : Unknown
Verified November 2005 by Soroka University Medical Center. Recruitment status was: Not yet recruiting
The purpose of this study is to evaluate the effectiveness of the biofeedback gait training device in improving load bearing over an operated limb, during post-operative gait training therapy. The effectiveness of the device will also be tested in self-training at home.
Condition or disease
Ankle InjuriesFemoral Neck Fractures
Device: SmartStep(tm) biofeedback device
To evaluate the effectiveness of the biofeedback gait training device as a biofeedback training therapeutic tool in improving body-weight bearing over the affected lower limb, quality of gait, level of ambulation and physical independence during rehabilitation, in patients after orthopedic procedures during gait therapy training, and as a biofeedback device for self-training at home.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 85 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Rehabilitation after operation
Patient is allowed full weight bearing
Patient is motivated and able to communicate and understands orders
Patient is able to walk 10 meters
Patient filled out agreement and consent form
Activity limitation due to medical disorder, medications, or emotional status.
Pain markedly obstructs gait ability
Documented peripheral neuropathy
Functional limitation prior to the current condition
Premorbid, ongoing major depression or psychosis
Serious early complications
Terminally ill patients
Participation in current or recent (within 60 days prior to surgery) clinical trial